Literature DB >> 16885934

Nutritional determinants of plasma total homocysteine distribution in the Canary Islands.

P Henríquez1, J Doreste, R Deulofeu, M D Fiuza, L Serra-Majem.   

Abstract

OBJECTIVE: We sought to define plasma homocysteine reference values in healthy individuals in the Canary Islands and to determine its relations to folate and vitamin B12 intakes and concentrations.
DESIGN: Cross-sectional study.
SETTING: Population-based representative sample of 557 participants, aged 18-65 years, from the Canary Islands Nutrition Survey (ENCA).
SUBJECTS: All participants completed two 24-h dietary recalls and a general questionnaire collecting socio-demographic and health-related lifestyle information.
INTERVENTIONS: Plasma homocysteine and serum vitamin B12 levels were measured by immunoassay, whereas folate levels through an automated ionic capturing method.
RESULTS: Median plasma homocysteine was 11.9 micromol/l, higher in men (13.1 micromol/l) than in women (10.9 micromol/l) (P<0.001) and positively associated with age in both sexes (P<0.001). The prevalence of hyperhomocysteinaemia (> or = 15 micromol/l), 21.4%, was also greater in men (32.2%) than in women (13.4%). There were significant negative correlations between plasma homocysteine and serum (r=-0.32, P<0.001) and erythrocyte (r=-0.26, P<0.001) folate, as well as serum vitamin B12 (r=-0.28, P<0.001) concentrations. When divided in quartiles of vitamin intakes or concentrations, men with the lowest vitamin B12 and folate serum values had significantly higher plasma homocysteine concentrations than those in the other three quartiles. In women, hyperhomocysteinaemia was higher in the lowest quartiles of folate intake and serum and erythrocyte folate concentrations.
CONCLUSIONS: These data provide further evidence that hyperhomocysteinaemia is a sensitive marker of inadequate folate and vitamin B12 status, allowing for the identification of those with greatest need for nutritional interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16885934     DOI: 10.1038/sj.ejcn.1602490

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  6 in total

1.  A folate receptor alpha double-mutated haplotype 1816delC-1841A is distributed throughout Eurasia and associated with lower erythrocyte folate levels.

Authors:  Torbjörn K Nilsson; Margit Laanpere; Signe Altmäe; Lluís Serra-Majem; Andres Salumets
Journal:  Mol Biol Rep       Date:  2011-09-22       Impact factor: 2.316

2.  Changes in predictors and status of homocysteine in young male adults after a dietary intervention with vegetables, fruits and bread.

Authors:  Tonje Holte Stea; Mohammad Azam Mansoor; Margareta Wandel; Solveig Uglem; Wenche Frølich
Journal:  Eur J Nutr       Date:  2008-06-02       Impact factor: 5.614

3.  Oral versus intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency: a pragmatic, randomised, multicentre, non-inferiority clinical trial undertaken in the primary healthcare setting (Project OB12).

Authors:  Teresa Sanz-Cuesta; Paloma González-Escobar; Rosario Riesgo-Fuertes; Sofía Garrido-Elustondo; Isabel del Cura-González; Jesús Martín-Fernández; Esperanza Escortell-Mayor; Francisco Rodríguez-Salvanés; Marta García-Solano; Rocío González-González; María Ángeles Martín-de la Sierra-San Agustín; Carmen Olmedo-Lucerón; María Luisa Sevillano Palmero; Carmen Mateo-Ruiz; Beatriz Medina-Bustillo; Antonio Valdivia-Pérez; Francisca García-de Blas-González; José Enrique Mariño-Suárez; Ricardo Rodríguez-Barrientos; Gloria Ariza-Cardiel; Luisa María Cabello-Ballesteros; Elena Polentinos-Castro; Milagros Rico-Blázquez; Ma Teresa Rodríguez-Monje; Sonia Soto-Díaz; Susana Martín-Iglesias; Ramón Rodríguez-González; Irene Bretón-Lesmes; María Vicente-Herrero; Jesús Sánchez-Díaz; Tomás Gómez-Gascón; Mercedes Drake-Canela; Ángel Asúnsolo-del Barco
Journal:  BMC Public Health       Date:  2012-05-31       Impact factor: 3.295

4.  Prevalence and risk factors for hyperhomocysteinemia: a population-based cross-sectional study from Hunan, China.

Authors:  Yide Yang; Yuan Zeng; Shuqian Yuan; Ming Xie; Yanhui Dong; Jian Li; Quanyuan He; Xiangli Ye; Yuan Lv; Carl-Friedrich Hocher; Bernhard K Kraemer; Xiuqin Hong; Berthold Hocher
Journal:  BMJ Open       Date:  2021-12-06       Impact factor: 2.692

5.  Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: a pragmatic, randomised, non-inferiority clinical trial (OB12).

Authors:  Teresa Sanz-Cuesta; Esperanza Escortell-Mayor; Isabel Cura-Gonzalez; Jesus Martin-Fernandez; Rosario Riesgo-Fuertes; Sofía Garrido-Elustondo; Jose Enrique Mariño-Suárez; Mar Álvarez-Villalba; Tomás Gómez-Gascón; Inmaculada González-García; Paloma González-Escobar; Concepción Vargas-Machuca Cabañero; Mar Noguerol-Álvarez; Francisca García de Blas-González; Raquel Baños-Morras; Concepción Díaz-Laso; Nuria Caballero-Ramírez; Alicia Herrero de-Dios; Rosa Fernández-García; Jesús Herrero-Hernández; Belen Pose-García; María Luisa Sevillano-Palmero; Carmen Mateo-Ruiz; Beatriz Medina-Bustillo; Monica Aguilar-Jiménez
Journal:  BMJ Open       Date:  2020-08-20       Impact factor: 2.692

Review 6.  Current Nanocarrier Strategies Improve Vitamin B12 Pharmacokinetics, Ameliorate Patients' Lives, and Reduce Costs.

Authors:  Marco Fidaleo; Stefano Tacconi; Carolina Sbarigia; Daniele Passeri; Marco Rossi; Ada Maria Tata; Luciana Dini
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.